Dr Frankel

Editor-in-Chief:  Professor Arthur E. Frankel

Dr. Arthur Frankel is Director of Hematology/Oncology at Scott & White Hospital in Temple, Texas. He is also Executive Director at the Scott & White Cancer Research Institute and Professor of Medicine at Texas A&M Health Science Center, College of Medicine.

Dr. Frankel earned his MD from Harvard Medical School and conducted his Medicine Internship at Yale University. Soon after completing his degree, Dr. Frankel began as a Research Scientist with the National Institute of Health and later completed his Medicine Residency and Oncology Fellowship at Stanford University. He is Board Certified in Internal Medicine, Medical Oncology and Hematology. Dr. Frankel is a member of the American Society of Clinical Oncology, American Society of Hematology and American Association of Cancer Research.

Dr. Frankel's main focus is combining the clinical practice of hematology/oncology with an investigative cancer drug development program to better move targeted cancer therapeutics into the clinical setting. He has participated in the development of targeted peptide toxins also called immunotoxins for melanoma, breast cancer, ovarian cancer, leukemia, lymphoma, chronic pain, prostate cancer, and thyroid cancer. He has performed phase I clinical trials for many of these agents. He has over 190 peer-reviewed articles, has edited three books, organized for international symposia and received grants from the American Cancer Society, the Leukemia and Lymphoma Society, NIH and the Van Andel Foundation.